Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,166.00
-65.00 (-5.28%)
At close: Oct 28, 2026

Prestige Biologics Statistics

Total Valuation

KOSDAQ:334970 has a market cap or net worth of KRW 90.66 billion. The enterprise value is 185.02 billion.

Market Cap90.66B
Enterprise Value 185.02B

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

KOSDAQ:334970 has 77.75 million shares outstanding. The number of shares has increased by 5.58% in one year.

Current Share Class 77.75M
Shares Outstanding 77.75M
Shares Change (YoY) +5.58%
Shares Change (QoQ) n/a
Owned by Insiders (%) 20.34%
Owned by Institutions (%) 0.07%
Float 30.82M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.40
PB Ratio 1.00
P/TBV Ratio 1.02
P/FCF Ratio 99.52
P/OCF Ratio 28.31
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 6.94
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 203.11

Financial Position

The company has a current ratio of 0.29, with a Debt / Equity ratio of 1.12.

Current Ratio 0.29
Quick Ratio 0.08
Debt / Equity 1.12
Debt / EBITDA n/a
Debt / FCF 111.21
Interest Coverage -7.13

Financial Efficiency

Return on equity (ROE) is -45.40% and return on invested capital (ROIC) is -14.73%.

Return on Equity (ROE) -45.40%
Return on Assets (ROA) -11.48%
Return on Invested Capital (ROIC) -14.73%
Return on Capital Employed (ROCE) -43.23%
Weighted Average Cost of Capital (WACC) 6.01%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.10
Inventory Turnover 1.69

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -62.57% in the last 52 weeks. The beta is 0.44, so KOSDAQ:334970's price volatility has been lower than the market average.

Beta (5Y) 0.44
52-Week Price Change -62.57%
50-Day Moving Average 1,524.14
200-Day Moving Average 2,140.22
Relative Strength Index (RSI) 21.82
Average Volume (20 Days) 105,888

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, KOSDAQ:334970 had revenue of KRW 26.67 billion and -51.22 billion in losses. Loss per share was -658.76.

Revenue26.67B
Gross Profit -19.42B
Operating Income -49.30B
Pretax Income -51.22B
Net Income -51.22B
EBITDA -32.44B
EBIT -49.30B
Loss Per Share -658.76
Full Income Statement

Balance Sheet

The company has 6.94 billion in cash and 101.31 billion in debt, with a net cash position of -94.36 billion or -1,213.64 per share.

Cash & Cash Equivalents 6.94B
Total Debt 101.31B
Net Cash -94.36B
Net Cash Per Share -1,213.64
Equity (Book Value) 90.46B
Book Value Per Share 1,163.38
Working Capital -107.60B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.20 billion and capital expenditures -2.29 billion, giving a free cash flow of 910.95 million.

Operating Cash Flow 3.20B
Capital Expenditures -2.29B
Depreciation & Amortization 16.87B
Net Borrowing 5.14B
Free Cash Flow 910.95M
FCF Per Share 11.72
Full Cash Flow Statement

Margins

Gross margin is -72.82%, with operating and profit margins of -184.89% and -192.09%.

Gross Margin -72.82%
Operating Margin -184.89%
Pretax Margin -192.09%
Profit Margin -192.09%
EBITDA Margin -121.64%
EBIT Margin -184.89%
FCF Margin 3.42%

Dividends & Yields

KOSDAQ:334970 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -5.58%
Shareholder Yield -5.58%
Earnings Yield -56.50%
FCF Yield 1.00%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

KOSDAQ:334970 has an Altman Z-Score of -1.77 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.77
Piotroski F-Score 5